Bo Qi

Over twenty-eight years of proven track record of achievement in major international leading biopharmaceutical companies (Amgen, ImClone Systems, and Eli Lilly) and China biotech (Generon/Evive) with the full CMC development, manufacturing and regulatory filing experience from five approved recombinant protein/monoclonal antibody products (e.g. Aranesp, Erbitux, Cyramza, etc.) and one innovative product that is currently in PPQ and BLA filing. Strong leadership and multitasking skills, priority focused with solid knowledge of pharmaceutical drug lifecycle. Demonstrated steady growth in responsibilities for both project and organizational management.